Repeat adrenocortical-sparing adrenalectomy for recurrent XXXX .

@entity1 @entity3935 @entity1911 @entity5 @entity134 @entity74 @entity13081 @entity280
PURPOSE: Many endocrine surgeons advocate subtotal adrenalectomy for @entity1 with bilateral @entity74 despite the risk of recurrence. However, as the effectiveness of this procedure for locally recurrent @entity1911 is not well known, we investigated two @entity1 who underwent this operation. METHODS: We performed repeat subtotal adrenalectomy for recurrent @entity74 in two @entity1 who had undergone primary subtotal adrenalectomy. RESULTS: @entity1 1 was a 23-year-old @entity1 with @entity13081 , in whom about 25% of the right adrenal gland was left in situ. @entity1 2 was a 22-year-old @entity1 with @entity280 , in whom about 25% of both normal adrenal glands was left in situ. No @entity134 replacement was required postoperatively, and adrenocorticotropic hormone stimulation revealed sufficient adrenocortical function in both @entity1 . No sign of recurrent @entity1911 has been found in 96 months and 11 months of follow-up, respectively. CONCLUSION: Recurrent hereditary benign @entity1911 after subtotal adrenalectomy may be treated successfully by repeated subtotal adrenalectomy. However, the risk of recurrence and @entity5 must be weighed carefully against the risk of lifelong @entity134 replacement and potential @entity3935 . Thus, repeated subtotal adrenalectomy should be considered for selective @entity1 who want to avoid @entity134 replacement.
